← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3295)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial. (2018/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Unusual acute liver failure from small cell carcinoma of the lung. (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Schlafen-11 (SLFN11): a step forward towards personalized medicine in small-cell lung cancer? (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Specific copy number changes as potential predictive markers for adjuvant chemotherapy in non-small cell lung cancer. (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Neoadjuvant immunotherapy in non-small cell lung cancer: the sooner the better? (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Old myths about old patients: the case of non-small cell lung cancer. (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial for "Longitudinal cell-free DNA analysis in patients with small cell lung cancer reveals dynamic insights into treatment efficacy and disease relapse". (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Immunotherapies in the management of epidermal growth factor receptor mutated non-small cell lung cancer: a role will be found? (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Immunotherapy in tyrosine kinase inhibitor-naïve advanced epidermal growth factor receptor-mutant non-small cell lung cancer-driving down a precarious road in driver-mutated lung cancer. (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary? (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Case closed: another prophylactic cranial irradiation trial for stage 3 non-small cell lung cancer fails to improve overall survival. (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle? (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. VISTA/PD-1H: a potential target for non-small cell lung cancer immunotherapy. (2018/12/01) ♡
- Left mediastinal node dissection after arterial ligament transection via video-assisted thoracoscopic surgery for potentially advanced stage I non-small cell lung cancer. (2018/12/01) ♡
- Prognostic value of tumor solid-part size and solid-part volume in patients with clinical stage I non-small cell lung cancer. (2018/12/01) ♡
- Surgery of primary non-small cell lung cancer with oligometastasis: analysis of 172 cases. (2018/12/01) ♡
- Impact of examined lymph node counts on survival of patients with stage IA non-small cell lung cancer undergoing sublobar resection. (2018/12/01) ♡
- Effectiveness and safety of PD-1/PD-L1 or CTLA4 inhibitors combined with chemotherapy as a first-line treatment for lung cancer: A meta-analysis. (2018/12/01) ♡
- Occult stage IIIA-N2 patients have excellent overall survival with initial surgery. (2018/12/01) ♡
- First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis. (2018/12/01) ♡
- Programmed cell death protein-1/programmed death-ligand 1 blockade enhances the antitumor efficacy of adoptive cell therapy against non-small cell lung cancer. (2018/12/01) ♡
- Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer. (2018/12/01) ♡
- Predictive factors of postoperative survival among patients with pulmonary neuroendocrine tumor. (2018/12/01) ♡
- Evaluation of lobar lymph node metastasis in non-small cell lung carcinoma using modified total lesion glycolysis. (2018/12/01) ♡
- Three-arm robot-assisted thoracoscopic surgery for locally advanced N2 non-small cell lung cancer. (2018/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Are quality of life outcomes comparable following stereotactic radiotherapy and minimally invasive surgery for stage I lung cancer patients? (2018/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Upfront surgery is essential in selected patients with stage IIIA non-small cell lung cancer. (2018/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Common Mechanisms Linking Chronic Obstructive Pulmonary Disease and Lung Cancer. (2018/12/01) ♡
- Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor. (2018/12/01) ♡
- The overexpression of PDGF-BB and its receptor is correlated with lymphatic metastasis in patients with non-small cell lung cancer. (2018/12/01) ♡
- Increases in Serial Pretreatment (18)F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy. (2018/11/26) ♡
- How Good Is Positron Emission Tomography at Detecting Previously-Occult Metastatic Lung Cancer at Diagnosis? (2018/11/15) ♡
- trans-3-Methoxy-5-hydroxystilbene (MHS) from the rhizome of Alpinia nantonensis inhibits metastasis in human lung cancer cells. (2018/11/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. SKA2/FAM33A: A novel gene implicated in cell cycle, tumorigenesis, and psychiatric disorders. (2018/11/12) ♡
- Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer. (2018/11/08) ♡
- Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology. (2018/11/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion. (2018/11/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma. (2018/11/04) ♡
- The use of a standardized Chinese herbal formula in patients with advanced lung cancer: a feasibility study. (2018/11/01) ♡
- Epigallocatechin-3-gallate inhibited cancer stem cell-like properties by targeting hsa-mir-485-5p/RXRα in lung cancer. (2018/11/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis. (2018/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From nutraceutical to clinical trial: frontiers in Ganoderma development. (2018/11/01) ♡
- Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer. (2018/11/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis. (2018/11/01) ♡
- Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis. (2018/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Systems-Level Analysis of Mechanisms of Platycodon grandiflorum Based on A Network Pharmacological Approach. (2018/11/01) ♡
- Proportional weight loss in six months as a risk factor for mortality in stage IV non-small cell lung cancer. (2018/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Empyema caused by infection with Clostridium septicum in a patient with lung cancer. (2018/11/01) ♡
- Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway. (2018/11/01) ♡
- PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs. (2018/11/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.